언어 선택

HLA-A*0201 & B2M & HPV16-E7

제품 문의

HLA-A*0201 & B2M & HPV16-E7분자 배경

Human papillomavirus (HPV) is A kind of papillomavirus belonging to the milk polypoid virus family. It is a spherical DNA virus, which can cause the proliferation of squamous epithelium of human skin mucosa. HPV(human papillomavirus) for common warts, genital warts (condyloma acuminatum), and other symptoms. There are many types of human papillomavirus (HPV), with HPV 16 and 18 being high-risk types known to significantly increase the risk of cervical, vaginal and vulvar cancers in women and men. The human HLA-A*0201 HPV (YMLDLQPET) tetramer protein is a complex of HLA-A*0201 of the MHC Class I, B2M, and YMLDLQPET peptide of the HPV.

임상 약물 정보

영어 이름	연구 코드	연구 개발 단계	회사	적응증	임상 시험
Bosakitug	BSI-045B; TQC-2731; TQC2731	Phase 3 Clinical	Biosion Inc	Nasal Polyps; Sinusitis; Asthma; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic	상세
Ecleralimab	CSJ-117; NOV-14	Phase 2 Clinical	Novartis Pharma Ag	Asthma; Pulmonary Disease, Chronic Obstructive	상세
WIN-1001X	WIN-1001X	Phase 2 Clinical	Whanin Pharmaceutical Co Ltd	Nerve Degeneration; Parkinson Disease	상세
PF-07275315	PF-07275315	Phase 2 Clinical	Pfizer Inc	Dermatitis, Atopic	상세
Lunsekimig	SAR-443765	Phase 2 Clinical	Sanofi	Nasal Polyps; Asthma; Sinusitis; Inflammation	상세
AZD-8630	AZD-8630; AMG-104	Phase 2 Clinical	Astrazeneca Plc, Amgen Inc	Asthma	상세
SHR-1905	SHR-1905; AIO-001	Phase 2 Clinical		Nasal Polyps; Respiratory Tract Diseases; Sinusitis; Asthma; Pulmonary Disease, Chronic Obstructive	상세
CM-326(Connaught Biomedical Technology)	CM-326	Phase 2 Clinical	Keymed Biosciences Co Ltd	Nose Diseases; Nasal Polyps; Asthma; Sinusitis; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic	상세
PF-06342674	RN-168; PF-6342674; PF-06342674; ZB-168	Phase 1 Clinical	Pfizer Inc	Diabetes Mellitus, Type 1; Multiple Sclerosis	상세
HBM-9378	SKB378; HBM-9378	Phase 1 Clinical	Harbour Biomed, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd	Asthma	상세
HB-0056	HB-0056; HB0056	Phase 1 Clinical	Shanghai Huaota Biopharmaceutical Co Ltd	Asthma	상세
IBI-3002	IBI3002; IBI-3002	Phase 1 Clinical	Innovent Biologics(Suzhou) Co Ltd	Asthma	상세
GB-0895	GB-0895	Phase 1 Clinical		Immune System Diseases; Asthma	상세
STSA-1201	STSA-1201; STSA1201	Phase 1 Clinical		Asthma	상세
LQ043H	LQ043H	Phase 1 Clinical	Shanghai Novamab Biopharmaceuticals Co Ltd	Asthma	상세
GR2002	GR2002	Phase 1 Clinical	Genrix (Shanghai) Biopharmaceutical Co Ltd	Nasal Polyps; Asthma; Sinusitis; Dermatitis, Atopic	상세
QX-008N	QX008N; QX-008N	Phase 1 Clinical	Qyuns Therapeutics Co Ltd	Asthma; Pulmonary Disease, Chronic Obstructive	상세
BD-9	BD-9		Biolojic Design Inc		상세

시판 약물 정보

영어 이름	연구 코드	연구 개발 단계	회사	가장 빠른 브랜드 이름	가장 빠른 승인 국가	가장 빠른 적응증	가장 빠른 승인 회사	가장 빠른 승인 날짜	적응증	임상 시험
Tezepelumab	AMG-157; MEDI-9929	Approved	Amgen Inc	Tezspire	United States	Asthma	Astrazeneca Ab	2021-12-17	Eosinophilic Esophagitis; Hypersensitivity; Dermatitis, Atopic; Hypersensitivity, Immediate; Bronchial Diseases; Pulmonary Disease, Chronic Obstructive; Respiratory Hypersensitivity; Sinusitis; Asthma; Granulomatosis with Polyangiitis; Lung Diseases; Immune System Diseases; Chronic Urticaria; Respiratory Tract Diseases; Nasal Polyps; Anaphylaxis; Carcinoma; Lung Diseases, Obstructive	상세